Koninklijke Philips N.V.
PHG Healthcare Medical Devices
Koninklijke Philips N.V.’s revenue for fiscal 2025 (year ended December 2025) was $20.2 billion, up 3.47% from fiscal 2024.
- Revenue
- +0.55%
- EPS
- −85.0%
- Free cash flow
- +154.2%
- Total debt
- −4.96%
Quarter to September 2026, against a year earlier
Follow PHG
Alert me
Koninklijke Philips N.V. (PHG) Free cash flow
Koninklijke Philips N.V.'s free cash flow for fiscal 2025 was $580.4M, down 40.8% from $980.4M in fiscal 2024. Over the twelve months to 30 September 2026 it was $2.1B. Over the past ten years it has ranged from −$1.0B (fiscal 2022) to $2.1B (fiscal 2020); the current reading is higher than 27% of that period. Koninklijke Philips N.V. ranks 5th of 149 Medical Devices companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $580.4M | (40.80%) |
| FY2024 | $980.4M | (42.74%) |
| FY2023 | $1.7B | — |
| FY2022 | −$1.0B | — |
| FY2021 | $1.1B | (49.75%) |
| FY2020 | $2.1B | 79.48% |
| FY2019 | $1.2B | 1.59% |
| FY2018 | $1.2B | (13.40%) |
| FY2017 | $1.3B | 12.90% |
| FY2016 | $1.2B | 229.02% |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Sep 2026 | $440.2M | 69.92% |
| Jun 2026 | $259.1M | 690.53% |
| Mar 2026 | $32.8M | (97.63%) |
| Dec 2025 | $1.4B | 699.41% |
| 24 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| BSX Boston Scientific Corporation compare | $3.3B |
| PHG Koninklijke Philips N.V. | $2.1B |
| SNN Smith & Nephew SNATS, Inc. compare | $2.0B |
| GEHC GE HealthCare Technologies Inc. compare | $1.9B |
| EW Edwards Lifesciences Corporation compare | $1.4B |
| STE STERIS plc compare | $1.3B |
| ZBH Zimmer Biomet Holdings, Inc. compare | $1.1B |
| DXCM DexCom, Inc. compare | $1.1B |
| GKOS Glaukos Corporation compare | $36.0M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on PHG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement